ArticleBrain structure & function2026
Longitudinal visualization tools for advanced characterization of multiple sclerosis lesions using diffusion MRI and magnetization transfer imaging metrics.
Article in Brain structure & function, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Understanding how white matter microstructure supports functional network organization requires tools capable of characterizing tissue properties across multiple complementary metrics and spatial scales simultaneously. White matter pathology disrupts the relationship between microstructural tissue organization and network-level function in spatial and temporal patterns that reveal fundamental principles of white matter organization. Multiple sclerosis (MS) exemplifies this principle through heterogeneous lesion formation, demyelination, and axonal injury that disrupts white matter at multiple scales and in multiple ways. Advanced neuroimaging techniques, particularly diffusion MRI (dMRI) and magnetization transfer imaging (MTI), provide sensitive measures of distinct microstructural properties. However, the high dimensionality and longitudinal complexity of multi-metric datasets pose significant challenges for analyzing how these tissue changes relate to white matter network organization. We introduce five complementary visualization tools designed to integrate fixel-based multi-tensor, magnetization transfer, and isotropic volume fraction across multiple time points while preserving the spatial organization of white matter tracts and tissue compartments. The framework enables investigation of structure-function relationships at multiple scales: patient-level network disruption patterns, tract-specific vulnerability, bundle-section-specific regional variations, lesion-specific microstructural dynamics, and microstructural characteristics in tissue regions where lesions subsequently develop. Applied to longitudinal datasets from multiple MS patients over five scanning periods, the visualization framework provides a descriptive characterization of microstructural heterogeneity and permits hypothesis-generating exploration of white matter structure-function relationships. The framework provides tools for exploratory investigation of microstructural heterogeneity at multiple scales and provides research tools for hypothesis-generating examination of white matter structure-function relationships in pathology. It has potential applications for understanding how tissue-level microstructural changes vary across patients, bundles, and lesions. The framework is designed as a research visualization tool for hypothesis generation and should not be interpreted as providing clinical prognostic utility for which further validation against clinical outcomes is needed.
Indexed as
Identifiers
41882380What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.